Concepedia

Li‐Rong Yu

LY

Statistics

Publications

113

Citations

9.2K

H-Index

48

Active since

1996

Affiliations

Science Applications International Corporation (United States)(Current)

National Cancer Institute

National Center for Toxicological Research

United States Food and Drug Administration

Center for Cancer Research

Li‐Rong Yu is an author at Science Applications International Corporation (United States) specializing in life sciences, molecular biology, and biochemistry.

ORCID

Publications per year

1996–2024

113

Publications

113

Distinct roles of GCN5/PCAF‐mediated H3K9ac and CBP/p300‐mediated H3K18/27ac in nuclear receptor transactivation

Qihuang Jin, Li‐Rong Yu, Lifeng Wang et al. · The EMBO Journal · 2010 · 905 citations · Full text

, , +9

TGF‐β receptor‐activated p38 MAP kinase mediates Smad‐independent TGF‐β responses

Li‐Rong Yu · The EMBO Journal · 2002 · 727 citations · Full text

, , +11

Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases

Sunhwa Hong, Young‐Wook Cho, Li‐Rong Yu et al. · Proceedings of the National Academy of Sciences · 2007 · 711 citations · Full text

, , +17

Regulation of androgen receptor activity by tyrosine phosphorylation

Zhiyong Guo, Bojie Dai, Tianyun Jiang et al. · Cancer Cell · 2006 · 361 citations · Full text

, , +14

Transforming Growth Factor-β (TGF-β) Directly Activates the JAK1-STAT3 Axis to Induce Hepatic Fibrosis in Coordination with the SMAD Pathway

Liu-Ya Tang, Mary Heller, Zhaojing Meng et al. · Journal of Biological Chemistry · 2017 · 271 citations · Full text

, , +14

1–5 of 113